IT8348005A0 - 3,4-diammino-1,2,5-tiadiazoli dotati di attivita' antagonista dei recettori istaminici - Google Patents

3,4-diammino-1,2,5-tiadiazoli dotati di attivita' antagonista dei recettori istaminici

Info

Publication number
IT8348005A0
IT8348005A0 IT8348005A IT4800583A IT8348005A0 IT 8348005 A0 IT8348005 A0 IT 8348005A0 IT 8348005 A IT8348005 A IT 8348005A IT 4800583 A IT4800583 A IT 4800583A IT 8348005 A0 IT8348005 A0 IT 8348005A0
Authority
IT
Italy
Prior art keywords
histamines
thiadiazoles
diamino
receptor antagonist
antagonist activity
Prior art date
Application number
IT8348005A
Other languages
English (en)
Other versions
IT1164633B (it
Inventor
Crenshaw Ronnie Ray
Algieri Aldo Antonio
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IT8348005A0 publication Critical patent/IT8348005A0/it
Application granted granted Critical
Publication of IT1164633B publication Critical patent/IT1164633B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT48005/83A 1982-03-29 1983-03-28 3,4-diammino-1,2,5-tiadiazoli dotati di attivita' antagonista dei recettori istaminici IT1164633B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (2)

Publication Number Publication Date
IT8348005A0 true IT8348005A0 (it) 1983-03-28
IT1164633B IT1164633B (it) 1987-04-15

Family

ID=23429274

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48005/83A IT1164633B (it) 1982-03-29 1983-03-28 3,4-diammino-1,2,5-tiadiazoli dotati di attivita' antagonista dei recettori istaminici

Country Status (30)

Country Link
JP (2) JPS58180477A (it)
KR (1) KR880002209B1 (it)
AT (1) AT386599B (it)
AU (2) AU557577B2 (it)
BE (1) BE896291A (it)
CH (2) CH660880A5 (it)
CS (2) CS250229B2 (it)
DD (2) DD219768A5 (it)
DE (1) DE3311281A1 (it)
DK (2) DK166677B1 (it)
ES (3) ES520982A0 (it)
FR (2) FR2542741B1 (it)
GB (2) GB2117769B (it)
GR (1) GR78524B (it)
HU (2) HU196386B (it)
IE (1) IE55596B1 (it)
IL (1) IL68259A0 (it)
IT (1) IT1164633B (it)
LU (1) LU84716A1 (it)
MY (1) MY8700942A (it)
NL (1) NL8301063A (it)
NO (1) NO163055C (it)
NZ (1) NZ203726A (it)
OA (1) OA07356A (it)
PT (1) PT76459B (it)
SE (2) SE461040B (it)
SU (2) SU1419518A3 (it)
YU (1) YU44849B (it)
ZA (1) ZA832154B (it)
ZW (1) ZW7683A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
ES8505977A1 (es) 1985-06-16
YU44849B (en) 1991-04-30
GB2149406A (en) 1985-06-12
JPH06135925A (ja) 1994-05-17
DK166677B1 (da) 1993-06-28
DK141383A (da) 1983-09-30
JPS58180477A (ja) 1983-10-21
NO163055C (no) 1990-03-28
IE830686L (en) 1983-09-29
OA07356A (fr) 1984-08-31
CH660880A5 (de) 1987-05-29
KR840004095A (ko) 1984-10-06
ES8404683A1 (es) 1984-05-16
GB2149406B (en) 1986-01-02
ES520982A0 (es) 1984-05-16
LU84716A1 (fr) 1983-12-05
GB8432809D0 (en) 1985-02-06
NL8301063A (nl) 1983-10-17
PT76459B (en) 1986-03-11
ES527685A0 (es) 1985-06-16
IT1164633B (it) 1987-04-15
AU586037B2 (en) 1989-06-29
FR2597867B1 (fr) 1989-12-08
HU196386B (en) 1988-11-28
HU188742B (en) 1986-05-28
CS250229B2 (en) 1987-04-16
DE3311281A1 (de) 1983-11-24
SE8301725D0 (sv) 1983-03-28
AT386599B (de) 1988-09-12
ATA111083A (de) 1988-02-15
MY8700942A (en) 1987-12-31
ZA832154B (en) 1983-12-28
SE8704689L (sv) 1987-11-25
DK81192A (da) 1992-06-18
CH655111A5 (de) 1986-03-27
SE8704689D0 (sv) 1987-11-25
NO163055B (no) 1989-12-18
ZW7683A1 (en) 1984-01-04
AU1290783A (en) 1983-10-06
NO831100L (no) 1983-09-30
DD210909A5 (de) 1984-06-27
SE8301725L (sv) 1983-11-25
CS250240B2 (en) 1987-04-16
FR2597867A1 (fr) 1987-10-30
DK141383D0 (da) 1983-03-28
AU6327286A (en) 1987-01-08
SU1419518A3 (ru) 1988-08-23
KR880002209B1 (ko) 1988-10-18
DD219768A5 (de) 1985-03-13
GB2117769A (en) 1983-10-19
GR78524B (it) 1984-09-27
ES527686A0 (es) 1985-06-16
ES8505978A1 (es) 1985-06-16
SU1355123A3 (ru) 1987-11-23
FR2542741B1 (fr) 1989-12-08
PT76459A (en) 1983-04-01
BE896291A (fr) 1983-09-28
YU74483A (en) 1986-02-28
SE464302B (sv) 1991-04-08
JPH0568472B2 (it) 1993-09-29
NZ203726A (en) 1986-05-09
IL68259A0 (en) 1983-06-15
SE461040B (sv) 1989-12-18
FR2542741A1 (fr) 1984-09-21
GB2117769B (en) 1985-08-29
IE55596B1 (en) 1990-11-21
AU557577B2 (en) 1986-12-24
DK81192D0 (da) 1992-06-18
GB8308518D0 (en) 1983-05-05

Similar Documents

Publication Publication Date Title
ATE52495T1 (de) 2-(2'-nitrobenzoyl)-1,3-cyclohexandionen.
TR22585A (tr) Bazi 2-(2'-alkilbenzoil)-1,3-sikloheksandion'lar
FI865263A7 (fi) Laett, elektromagnetisk transduktor med stor effekt.
DE3586192D1 (de) Roentgen-anordnung.
FI834202A0 (fi) Slangformigt livsmedelshoelje, i synnerhet korvskinn med foerbaettrad avskalbarhet
NO167168C (no) Naerhetstenner med justerbart naerhetsomraade.
MX163934B (es) Procedimiento para preparar haluros de 1-metil-3,5,7-triaza-1-azoniatriciclodecano
FI894675A7 (fi) Muskarinreceptorantagonister.
OA07356A (fr) 3,4-Diamino-1,2,5-thiadiazoles substitués possedant une activité antagoniste du récepteur-H2 de l'histamine.
IT1227503B (it) Scaldabevande, specialmente per impiego domestico
IT8319192A0 (it) 1,3,4-tiadiazolo [3,2-a] pirimidine sostituite e procedimento per laloro preparazione
IT1140961B (it) Procedimento di preparazione di 5-mercapto-1,2,3-triazoli
TR20096A (tr) 2-(2'2'-dihalojenovinil)-ve 2(2',2',2'-trihalojenoetil)-siklomutano lar
IT8521217A0 (it) 3,4-diammino-1,2,5-tiadiazoli sostituiti aventi attivita'antagonista nei confronti di h2-recettori della istamina.
RO86358A2 (ro) Procedeu pentru prepararea unor 1,2,4-triazolil-u-il-propionitrili
NO851398L (no) Taakeleggingslegeme.
ES542499A0 (es) Derivados anillados de 4h-1,4-benzotiazina
DE3576574D1 (de) Roentgenvorrichtung.
ES264437Y (es) "porta-servilletas perfeccionado".
ES546784A0 (es) Procedimiento de obtencion del 2,6-dimetil-3-metoxicarbonil-4-(2-nitrofenil)-1,4-dihidropiridina-5-carboxilato de isobu-tilo
ES295626Y (es) Bolsa mejorada para urostomia
DE3574786D1 (de) Roentgenvorrichtung.
ES264126Y (es) "asiento perfeccionado".
ES263615Y (es) "asiento".
IT8423967A0 (it) Composti eterociclici dotati di attivita' terapeutica.